Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nithin Karakala

Concepts (129)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Kidney Injury
17
2025
400
3.590
Why?
Renal Replacement Therapy
6
2023
51
1.830
Why?
Nephrology
3
2021
26
1.250
Why?
Renal Dialysis
5
2023
196
1.200
Why?
Vitamin D-Binding Protein
1
2024
8
0.850
Why?
Complement C3
1
2024
21
0.850
Why?
Critical Care
2
2018
215
0.830
Why?
Point-of-Care Systems
2
2021
68
0.770
Why?
Cardiac Surgical Procedures
3
2025
331
0.730
Why?
Kidney
3
2025
717
0.700
Why?
Hepatorenal Syndrome
5
2023
12
0.680
Why?
Anticoagulants
3
2020
280
0.610
Why?
Kidney Failure, Chronic
3
2017
210
0.590
Why?
Respiratory Insufficiency
1
2020
119
0.560
Why?
Hemofiltration
1
2017
8
0.520
Why?
Postoperative Complications
1
2024
1099
0.520
Why?
Time-to-Treatment
1
2018
81
0.510
Why?
Extracorporeal Membrane Oxygenation
1
2020
305
0.500
Why?
Heparin
1
2016
86
0.450
Why?
Critical Illness
1
2017
316
0.430
Why?
Colloids
1
2013
4
0.410
Why?
Isotonic Solutions
1
2013
19
0.400
Why?
Albumins
1
2013
29
0.400
Why?
Fluid Therapy
1
2013
79
0.390
Why?
Mycobacterium Infections
1
2011
10
0.350
Why?
Mycobacterium
1
2011
28
0.350
Why?
Peritonitis
1
2011
24
0.350
Why?
Peritoneal Dialysis
1
2011
30
0.340
Why?
Vasoconstrictor Agents
3
2023
81
0.330
Why?
Sepsis
1
2013
240
0.320
Why?
Humans
25
2025
53246
0.320
Why?
Prognosis
7
2025
2118
0.310
Why?
Angiotensinogen
3
2013
12
0.290
Why?
Multiple Myeloma
1
2023
3082
0.280
Why?
Liver Cirrhosis
4
2023
246
0.240
Why?
Insulin-Like Growth Factor Binding Protein 1
1
2025
16
0.220
Why?
Male
12
2025
27444
0.190
Why?
Tandem Mass Spectrometry
1
2024
255
0.190
Why?
Aged
8
2025
10430
0.190
Why?
Creatinine
3
2018
158
0.180
Why?
Intensive Care Units
2
2014
243
0.180
Why?
Female
13
2025
28792
0.170
Why?
Middle Aged
9
2025
13422
0.160
Why?
Anti-Bacterial Agents
2
2018
832
0.150
Why?
Ultrasonography
1
2021
426
0.140
Why?
Rats
1
2024
3164
0.140
Why?
Uremia
1
2018
13
0.140
Why?
Water-Electrolyte Imbalance
1
2018
36
0.130
Why?
Mice
2
2025
5982
0.130
Why?
Vancomycin
1
2018
91
0.130
Why?
Catheterization, Central Venous
1
2017
80
0.120
Why?
Echocardiography
1
2019
408
0.120
Why?
Citrates
1
2016
11
0.120
Why?
Research Design
1
2018
373
0.120
Why?
Proteomics
1
2018
337
0.110
Why?
Predictive Value of Tests
4
2025
933
0.110
Why?
Arterial Pressure
1
2015
44
0.110
Why?
Randomized Controlled Trials as Topic
1
2018
630
0.110
Why?
Treatment Outcome
3
2021
5597
0.110
Why?
Clinical Competence
1
2018
406
0.110
Why?
Empyema, Pleural
1
2014
12
0.110
Why?
Hemorrhage
1
2016
226
0.100
Why?
Practice Guidelines as Topic
1
2017
502
0.100
Why?
Renin
1
2013
14
0.100
Why?
Hypertension
2
2019
554
0.100
Why?
Resuscitation
1
2013
72
0.100
Why?
Infusions, Intravenous
1
2013
211
0.100
Why?
Pneumonia
1
2014
123
0.100
Why?
Renin-Angiotensin System
1
2013
58
0.100
Why?
Animals
2
2025
13528
0.090
Why?
Disease Progression
3
2025
880
0.090
Why?
Adult
5
2020
14541
0.090
Why?
Patient Selection
1
2013
273
0.090
Why?
Diabetes Mellitus, Type 1
1
2014
224
0.090
Why?
Renal Insufficiency, Chronic
1
2014
205
0.080
Why?
Time Factors
1
2017
2992
0.080
Why?
Severity of Illness Index
3
2025
1049
0.080
Why?
Risk Assessment
1
2013
1368
0.070
Why?
Kidney Function Tests
2
2019
55
0.070
Why?
End Stage Liver Disease
2
2019
52
0.060
Why?
Diagnosis, Differential
2
2021
1038
0.050
Why?
Prospective Studies
2
2021
2412
0.050
Why?
Hospital Mortality
2
2017
457
0.050
Why?
Cisplatin
1
2025
282
0.050
Why?
Retrospective Studies
3
2025
6821
0.050
Why?
Mice, Knockout
1
2025
910
0.050
Why?
Lypressin
1
2021
1
0.040
Why?
Kidney Tubular Necrosis, Acute
1
2021
8
0.040
Why?
Catheterization
1
2021
95
0.040
Why?
Disease Models, Animal
1
2025
1517
0.040
Why?
Mice, Inbred C57BL
1
2025
1925
0.040
Why?
Survival Analysis
1
2021
659
0.040
Why?
Delayed Diagnosis
1
2019
30
0.040
Why?
Vena Cava, Inferior
1
2019
62
0.040
Why?
Diagnostic Errors
1
2019
68
0.040
Why?
Colorimetry
1
2018
16
0.030
Why?
Hemodynamics
1
2019
236
0.030
Why?
Cadaver
1
2018
90
0.030
Why?
Manikins
1
2018
33
0.030
Why?
Reproducibility of Results
1
2021
1221
0.030
Why?
Pilot Projects
1
2019
727
0.030
Why?
Risk Factors
2
2017
4018
0.030
Why?
Ultrasonography, Interventional
1
2018
138
0.030
Why?
United States
2
2021
5413
0.030
Why?
Self Efficacy
1
2018
139
0.030
Why?
Mass Spectrometry
1
2018
294
0.030
Why?
Fellowships and Scholarships
1
2018
124
0.030
Why?
Biopsy
1
2018
600
0.030
Why?
Octreotide
1
2015
9
0.030
Why?
Midodrine
1
2015
6
0.030
Why?
Norepinephrine
1
2015
106
0.030
Why?
Echocardiography, Doppler, Pulsed
1
2014
7
0.030
Why?
Thoracostomy
1
2014
10
0.030
Why?
Thoracoscopy
1
2014
17
0.030
Why?
Incidence
1
2017
1085
0.030
Why?
Positive-Pressure Respiration
1
2014
63
0.030
Why?
Cohort Studies
1
2018
1557
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2018
523
0.030
Why?
Area Under Curve
1
2013
185
0.020
Why?
Chi-Square Distribution
1
2013
291
0.020
Why?
ROC Curve
1
2013
246
0.020
Why?
Cardiovascular Diseases
1
2017
501
0.020
Why?
Multivariate Analysis
1
2013
598
0.020
Why?
Risk
1
2012
306
0.020
Why?
Up-Regulation
1
2013
456
0.020
Why?
Heart Failure
1
2017
531
0.020
Why?
Logistic Models
1
2013
947
0.020
Why?
Follow-Up Studies
1
2014
2318
0.020
Why?
Aged, 80 and over
1
2013
3495
0.010
Why?
Karakala's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description